Analysts at Leerink Swann reiterated an Outperform rating on shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. Leerink Swann currently has a rating …

Leerink Swann analysts reiterated its Outperform rating on Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) in a note to investors, making it one of the more closely watched stocks on Wall Street.Leerink Swann currently has a rating of Outperform on the shares. …